Jay W. Belle Isle

Before becoming LegalReader's Editor-in-Chief, Jay W. Belle Isle worked as a freelance copywriter with clients on four continents. Jay has a degree in Business Administration from Cleary University and a Juris Doctor from Thomas M. Cooley Law School. Jay has also worked as a contracts administrator for a DOD contractor specializing in vehicle armor.


Nevada Public Health Officials Silence Research on Impact of Natural Asbestos Deposits on Residents’ Health

Image: Public domain 5/5/2015 Nevada public health officials silence research on impact of natural asbestos deposits on residents’ health in what may be the most shocking instance of scientific censorship in recent history. Brenda Buck and Rod Metcalf, both professors at UNLV, discovered natural asbestos deposits approximately five years ago. Since that time, the pair


Senator Wants Television Coverage of U.S. Supreme Court Hearings

5/4/2015 The new chairman of the Senate Judiciary Committee (the first non-lawyer to hold the position), Sen. Chuck Grassley (R-IA), announced his plans to once again try to get television coverage of U.S. Supreme Court hearings. His latest effort, co-sponsored by Sen. Dick Durbin (D-IL), is the Cameras in the Courtroom Act of 2015, which


SCOTUS Will Examine Businesses’ Attempt to Curb Consumer Suits

Image: Public domain 5/4/2015 SCOTUS will examine businesses’ attempt to curb consumer suits in Spokeo v. Robins during the October term. If the justices side with Spokeo, Inc., an information firm that creates personal dossiers based on public information, business will have succeeded in further “corporatizing” law in America. Several federal statutes will be impacted


Vermont Law on GMO Labeling Stands

Image: SustainablePulse.com 5/1/2015 Vermont may well be drawing the line in U.S. soil regarding genetically modified food. U.S. District Court Judge Christina Reiss rule that the Vermont law on GMO labeling stands. The law, effective July 1, 2016, requires that all foods containing GMO ingredients be labeled as such. Needless to say, the Grocery Manufacturers


Medtronic Plc Agrees to Consent Decree with the FDA

5/1/2015 Pending approval from U.S. district court in Minnesota, Medtronic Plc agrees to consent decree with the FDA regarding its SynchroMed implantable drug pump. The company will correct problems that cause the pumps to deliver either too little or too much medication. The pumps are used for treating cancer and chronic pain patients and those


Michigan Insurance Companies Push Radical No-fault Auto Insurance Changes

Image: Shutterstock 4/30/2015 Under the stated reason of lowering the state’s highest-in-the-nation rates, Michigan insurance companies push radical no-fault auto insurance changes. To that end, the insurance industry is generously donating to state legislators and it seems to be working. The controversial bills seem to have been fast-tracked having only one Senate hearing and three


Takeda Settles Actos Cases for $2.3B

4/30/2015 In a great example of “CYA,” Takeda settles Actos cases for $2.3B. The agreement, yet to be approved by the plaintiffs, is a result of last year’s whopping smackdown in which a federal jury awarded a shopkeeper $9B, payable by Takeda and it’s former partner, Eli Lilly & Co. The court reduced that award


FDA Issued Stop Distribution Letters to Companies Producing BMPEA-containing Supplements

4/29/2015 Pressure from various officials finally got the FDA to step in regarding beta-methylphenethylamine (BMPEA), a substance used in weight loss, energy boosting and pre-workout supplements. The FDA issued stop distribution letters to companies producing BMPEA-containing supplements. This is a move I can support, unlike many other FDA positions on non-Big Pharma products. Image: Wikipedia,


Tort Reform: What a Waste of Time

4/29/2015 There aren’t too many dirtier words for lawyers than “tort reform.” Well actually, it’s properly referred to as tort “reform,” the placement of the quotation marks being all-important. Much like platform shoes, tort reform’s time is over. Frankly, it shouldn’t have even begun. Hence, the rallying cry of “Tort reform: what a waste of


States Asking Big Pharma About Astronomical Drug Prices

Colorful Pills by Vera Kratochvil Continual increases have states asking big pharma about astronomical drug prices. Many states are even proposing legislation that will force big pharma to share its development costs and profits as justification for ever-increasing prices. Tony DeLuca, a democratic representative in Pennsylvania, introduced legislation this week saying, “We need to have some